{"id":"W4303628848","doi":"10.1038/s42003-022-04011-6","title":"Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer’s disease","year":2022,"lang":"en","type":"article","venue":"Communications Biology","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Qatar National Research Fund; Genentech; U.S. National Library of Medicine; IXICO; H. Lundbeck A/S; Servier; Eisai; Northern California Institute for Research and Education; Foundation for the National Institutes of Health; Fonds National de la Recherche Luxembourg; Pfizer; Biogen; BioClinica; F. Hoffmann-La Roche; University of Southern California; Novartis Pharmaceuticals Corporation; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; Alzheimer's Disease Neuroimaging Initiative; Meso Scale Diagnostics; Alzheimer's Association; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Ceramide; Sphingomyelin; Disease; Computational biology; Alzheimer's disease; Biology; Bioinformatics; Medicine; Biochemistry; Pathology; Cholesterol","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005008565,0.0001574173,0.0001845689,0.00007009507,0.0005213311,0.00002264783,0.00148049,0.00006730341,0.0001060673],"category_scores_gemma":[0.000161898,0.0001272265,0.0001129145,0.0002708623,0.0002366664,0.000004761969,0.001045601,0.0003052779,0.00001483416],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001861989,"about_ca_system_score_gemma":0.0001957635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001940979,"about_ca_topic_score_gemma":0.00005025701,"domain_scores_codex":[0.9981771,0.0008846656,0.0003089678,0.0003080024,0.00006420357,0.0002570328],"domain_scores_gemma":[0.9978854,0.00009512937,0.000141626,0.001755813,0.00005640656,0.0000655966],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001267077,0.0004479222,0.01497127,0.00000312415,0.0001910738,0.000002076609,0.0006006665,0.0004084313,0.9751912,0.002371913,0.0001466974,0.005538919],"study_design_scores_gemma":[0.001842358,0.0002385334,0.06313954,0.000009519681,0.0001678728,0.00001901854,0.001233456,0.007803545,0.01861334,0.001797518,0.9044768,0.0006585491],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9258623,0.06386396,0.0007206904,0.00809372,0.000360527,0.000617108,0.000224582,0.00003917675,0.0002180089],"genre_scores_gemma":[0.9931098,0.001485427,0.0008068197,0.002726196,0.00009699665,0.0004461294,0.001238401,0.0000223922,0.00006788507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9565778,"threshold_uncertainty_score":0.5188146,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1048340056253713,"score_gpt":0.3661946906333956,"score_spread":0.2613606850080242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}